ID   FAS_RAT                 Reviewed;        2505 AA.
AC   P12785; O09187; O09190; Q63577; Q64717;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 3.
DT   24-JUL-2024, entry version 214.
DE   RecName: Full=Fatty acid synthase;
DE            EC=2.3.1.85 {ECO:0000269|PubMed:15715522, ECO:0000269|PubMed:8250834, ECO:0000269|PubMed:8756713};
DE   AltName: Full=Type I FAS {ECO:0000303|PubMed:18096506};
DE   Includes:
DE     RecName: Full=[Acyl-carrier-protein] S-acetyltransferase;
DE              EC=2.3.1.38 {ECO:0000269|PubMed:18096506, ECO:0000269|PubMed:8250834, ECO:0000269|PubMed:8756713};
DE   Includes:
DE     RecName: Full=[Acyl-carrier-protein] S-malonyltransferase;
DE              EC=2.3.1.39 {ECO:0000269|PubMed:8250834};
DE   Includes:
DE     RecName: Full=3-oxoacyl-[acyl-carrier-protein] synthase;
DE              EC=2.3.1.41 {ECO:0000269|PubMed:15715522, ECO:0000269|PubMed:8250834, ECO:0000269|PubMed:8756713};
DE   Includes:
DE     RecName: Full=3-oxoacyl-[acyl-carrier-protein] reductase;
DE              EC=1.1.1.100 {ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834, ECO:0000305|PubMed:8756713};
DE   Includes:
DE     RecName: Full=3-hydroxyacyl-[acyl-carrier-protein] dehydratase;
DE              EC=4.2.1.59 {ECO:0000269|PubMed:18096506, ECO:0000269|PubMed:8250834};
DE   Includes:
DE     RecName: Full=Enoyl-[acyl-carrier-protein] reductase;
DE              EC=1.3.1.39 {ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834, ECO:0000305|PubMed:8756713};
DE   Includes:
DE     RecName: Full=Acyl-[acyl-carrier-protein] hydrolase;
DE              EC=3.1.2.14;
GN   Name=Fasn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2717611; DOI=10.1073/pnas.86.9.3114;
RA   Amy C.M., Witkowski A., Naggert J., Williams B., Randhawa Z., Smith S.;
RT   "Molecular cloning and sequencing of cDNAs encoding the entire rat fatty
RT   acid synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:3114-3118(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=1339331; DOI=10.3109/10425179209020817;
RA   Beck K.F., Schreglmann R., Stathopulos I., Klein H., Hoch J., Schweizer M.;
RT   "The fatty acid synthase (FAS) gene and its promoter in Rattus
RT   norvegicus.";
RL   DNA Seq. 2:359-386(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1736293; DOI=10.1073/pnas.89.3.1105;
RA   Amy C.M., Williams-Ahlf B., Naggert J., Smith S.;
RT   "Intron-exon organization of the gene for the multifunctional animal fatty
RT   acid synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1105-1108(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 75-2505.
RC   STRAIN=Sprague-Dawley; TISSUE=Mammary gland;
RX   PubMed=2915923; DOI=10.1093/nar/17.2.567;
RA   Schweizer M., Takabeyashi K., Beck K.F., Schreglmann R.;
RT   "Rat mammary gland fatty acid synthase: localization of the constituent
RT   domains and two functional polyadenylation/termination signals in the
RT   cDNA.";
RL   Nucleic Acids Res. 17:567-586(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1921-2324.
RC   TISSUE=Mammary gland;
RX   PubMed=3109907; DOI=10.1111/j.1432-1033.1987.tb11482.x;
RA   Witlowski A., Naggert J., Mikkelsen J., Smith S.;
RT   "Molecular cloning and sequencing of a cDNA encoding the acyl carrier
RT   protein and its flanking domains in the mammalian fatty acid synthetase.";
RL   Eur. J. Biochem. 165:601-606(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2085-2505.
RC   TISSUE=Mammary gland;
RX   PubMed=2891707; DOI=10.1016/s0021-9258(19)57278-7;
RA   Naggert J., Witkowski A., Mikkelsen J., Smith S.;
RT   "Molecular cloning and sequencing of a cDNA encoding the thioesterase
RT   domain of the rat fatty acid synthetase.";
RL   J. Biol. Chem. 263:1146-1150(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE OF 2377-2413, AND INDUCTION.
RX   PubMed=2313386; DOI=10.1093/jn/120.2.218;
RA   Clarke S.D., Armstrong M.K., Jump D.B.;
RT   "Nutritional control of rat liver fatty acid synthase and S14 mRNA
RT   abundance.";
RL   J. Nutr. 120:218-224(1990).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RX   PubMed=8250834; DOI=10.1042/bj2960143;
RA   Joshi A.K., Smith S.;
RT   "Construction of a cDNA encoding the multifunctional animal fatty acid
RT   synthase and expression in Spodoptera frugiperda cells using baculoviral
RT   vectors.";
RL   Biochem. J. 296:143-149(1993).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=8756713; DOI=10.1021/bi960910m;
RA   Witkowski A., Joshi A., Smith S.;
RT   "Fatty acid synthase: in vitro complementation of inactive mutants.";
RL   Biochemistry 35:10569-10575(1996).
RN   [10]
RP   FUNCTION.
RX   PubMed=9405069; DOI=10.1021/bi972242q;
RA   Witkowski A., Joshi A.K., Smith S.;
RT   "Characterization of the interthiol acyltransferase reaction catalyzed by
RT   the beta-ketoacyl synthase domain of the animal fatty acid synthase.";
RL   Biochemistry 36:16338-16344(1997).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND PATHWAY.
RX   PubMed=15715522; DOI=10.1042/bj20041963;
RA   Rendina A.R., Cheng D.;
RT   "Characterization of the inactivation of rat fatty acid synthase by C75:
RT   inhibition of partial reactions and protection by substrates.";
RL   Biochem. J. 388:895-903(2005).
RN   [12]
RP   INTERACTION WITH CEACAM1.
RX   PubMed=16054098; DOI=10.1016/j.cmet.2005.06.001;
RA   Najjar S.M., Yang Y., Fernstroem M.A., Lee S.J., Deangelis A.M.,
RA   Rjaily G.A., Al-Share Q.Y., Dai T., Miller T.A., Ratnam S., Ruch R.J.,
RA   Smith S., Lin S.H., Beauchemin N., Oyarce A.M.;
RT   "Insulin acutely decreases hepatic fatty acid synthase activity.";
RL   Cell Metab. 2:43-53(2005).
RN   [13]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=16969344; DOI=10.1038/sj.bjc.6603350;
RA   Zhao W., Kridel S., Thorburn A., Kooshki M., Little J., Hebbar S.,
RA   Robbins M.;
RT   "Fatty acid synthase: a novel target for antiglioma therapy.";
RL   Br. J. Cancer 95:869-878(2006).
RN   [14]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=18096506; DOI=10.1016/j.chembiol.2007.11.007;
RA   Pasta S., Witkowski A., Joshi A.K., Smith S.;
RT   "Catalytic residues are shared between two pseudosubunits of the
RT   dehydratase domain of the animal fatty acid synthase.";
RL   Chem. Biol. 14:1377-1385(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-725; SER-1578; SER-2151 AND
RP   SER-2191, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [16]
RP   STRUCTURE BY NMR OF 2114-2202.
RX   PubMed=12926246; DOI=10.1039/b208941f;
RA   Reed M.A.C., Schweizer M., Szafranska A.E., Arthur C., Nicholson T.P.,
RA   Cox R.J., Crosby J., Crump M.P., Simpson T.J.;
RT   "The type I rat fatty acid synthase ACP shows structural homology and
RT   analogous biochemical properties to type II ACPs.";
RL   Org. Biomol. Chem. 1:463-471(2003).
CC   -!- FUNCTION: Fatty acid synthetase is a multifunctional enzyme that
CC       catalyzes the de novo biosynthesis of long-chain saturated fatty acids
CC       starting from acetyl-CoA and malonyl-CoA in the presence of NADPH. This
CC       multifunctional protein contains 7 catalytic activities and a site for
CC       the binding of the prosthetic group 4'-phosphopantetheine of the acyl
CC       carrier protein ([ACP]) domain. {ECO:0000269|PubMed:15715522,
CC       ECO:0000269|PubMed:18096506, ECO:0000269|PubMed:8250834,
CC       ECO:0000269|PubMed:8756713, ECO:0000305|PubMed:9405069}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + n malonyl-CoA + 2n NADPH + 2n H(+) = a long-chain
CC         fatty acid + (n+1) CoA + n CO2 + 2n NADP(+).; EC=2.3.1.85;
CC         Evidence={ECO:0000269|PubMed:15715522, ECO:0000269|PubMed:8250834,
CC         ECO:0000269|PubMed:8756713};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + holo-[ACP] = acetyl-[ACP] + CoA;
CC         Xref=Rhea:RHEA:41788, Rhea:RHEA-COMP:9621, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78446; EC=2.3.1.38;
CC         Evidence={ECO:0000269|PubMed:18096506, ECO:0000269|PubMed:8250834,
CC         ECO:0000269|PubMed:8756713};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41789;
CC         Evidence={ECO:0000269|PubMed:18096506, ECO:0000269|PubMed:8250834,
CC         ECO:0000269|PubMed:8756713};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=holo-[ACP] + malonyl-CoA = CoA + malonyl-[ACP];
CC         Xref=Rhea:RHEA:41792, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78449; EC=2.3.1.39;
CC         Evidence={ECO:0000269|PubMed:8250834};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41793;
CC         Evidence={ECO:0000269|PubMed:8250834};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a fatty acyl-[ACP] + H(+) + malonyl-[ACP] = a 3-oxoacyl-[ACP]
CC         + CO2 + holo-[ACP]; Xref=Rhea:RHEA:22836, Rhea:RHEA-COMP:9623,
CC         Rhea:RHEA-COMP:9685, Rhea:RHEA-COMP:9916, Rhea:RHEA-COMP:14125,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78449, ChEBI:CHEBI:78776, ChEBI:CHEBI:138651;
CC         EC=2.3.1.41; Evidence={ECO:0000269|PubMed:15715522,
CC         ECO:0000269|PubMed:8250834, ECO:0000269|PubMed:8756713};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22837;
CC         Evidence={ECO:0000269|PubMed:15715522, ECO:0000269|PubMed:8250834,
CC         ECO:0000269|PubMed:8756713};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3R)-hydroxyacyl-[ACP] + NADP(+) = a 3-oxoacyl-[ACP] + H(+)
CC         + NADPH; Xref=Rhea:RHEA:17397, Rhea:RHEA-COMP:9916, Rhea:RHEA-
CC         COMP:9945, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78776, ChEBI:CHEBI:78827; EC=1.1.1.100;
CC         Evidence={ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:17399;
CC         Evidence={ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3R)-hydroxyacyl-[ACP] = a (2E)-enoyl-[ACP] + H2O;
CC         Xref=Rhea:RHEA:13097, Rhea:RHEA-COMP:9925, Rhea:RHEA-COMP:9945,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78784, ChEBI:CHEBI:78827; EC=4.2.1.59;
CC         Evidence={ECO:0000269|PubMed:18096506, ECO:0000269|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13098;
CC         Evidence={ECO:0000269|PubMed:18096506, ECO:0000269|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2,3-saturated acyl-[ACP] + NADP(+) = a (2E)-enoyl-[ACP] +
CC         H(+) + NADPH; Xref=Rhea:RHEA:22564, Rhea:RHEA-COMP:9925, Rhea:RHEA-
CC         COMP:9926, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78784, ChEBI:CHEBI:78785; EC=1.3.1.39;
CC         Evidence={ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:22566;
CC         Evidence={ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + hexadecanoyl-[ACP] = H(+) + hexadecanoate + holo-[ACP];
CC         Xref=Rhea:RHEA:41932, Rhea:RHEA-COMP:9652, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:64479, ChEBI:CHEBI:78483; EC=3.1.2.14;
CC         Evidence={ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41933;
CC         Evidence={ECO:0000305|PubMed:15715522, ECO:0000305|PubMed:8250834,
CC         ECO:0000305|PubMed:8756713};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-[ACP] + H(+) + malonyl-[ACP] = 3-oxobutanoyl-[ACP] +
CC         CO2 + holo-[ACP]; Xref=Rhea:RHEA:41800, Rhea:RHEA-COMP:9621,
CC         Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9625, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78446, ChEBI:CHEBI:78449, ChEBI:CHEBI:78450;
CC         Evidence={ECO:0000269|PubMed:8250834};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41801;
CC         Evidence={ECO:0000269|PubMed:8250834};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxobutanoyl-[ACP] + H(+) + NADPH = (3R)-hydroxybutanoyl-
CC         [ACP] + NADP(+); Xref=Rhea:RHEA:41804, Rhea:RHEA-COMP:9625,
CC         Rhea:RHEA-COMP:9626, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78450, ChEBI:CHEBI:78451;
CC         Evidence={ECO:0000305|PubMed:8250834};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41805;
CC         Evidence={ECO:0000305|PubMed:8250834};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxybutanoyl-[ACP] = (2E)-butenoyl-[ACP] + H2O;
CC         Xref=Rhea:RHEA:41808, Rhea:RHEA-COMP:9626, Rhea:RHEA-COMP:9627,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78451, ChEBI:CHEBI:78453;
CC         Evidence={ECO:0000269|PubMed:18096506, ECO:0000305|PubMed:8250834};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41809;
CC         Evidence={ECO:0000269|PubMed:18096506, ECO:0000305|PubMed:8250834};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-butenoyl-[ACP] + H(+) + NADPH = butanoyl-[ACP] + NADP(+);
CC         Xref=Rhea:RHEA:41812, Rhea:RHEA-COMP:9627, Rhea:RHEA-COMP:9628,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78453, ChEBI:CHEBI:78454;
CC         Evidence={ECO:0000305|PubMed:8250834};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41813;
CC         Evidence={ECO:0000305|PubMed:8250834};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-[ACP] + H(+) + malonyl-[ACP] = 3-oxohexanoyl-[ACP] +
CC         CO2 + holo-[ACP]; Xref=Rhea:RHEA:41820, Rhea:RHEA-COMP:9623,
CC         Rhea:RHEA-COMP:9628, Rhea:RHEA-COMP:9629, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78449, ChEBI:CHEBI:78454, ChEBI:CHEBI:78456;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41821;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxohexanoyl-[ACP] + H(+) + NADPH = (3R)-hydroxyhexanoyl-
CC         [ACP] + NADP(+); Xref=Rhea:RHEA:41824, Rhea:RHEA-COMP:9629,
CC         Rhea:RHEA-COMP:9630, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78456, ChEBI:CHEBI:78457;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41825;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxyhexanoyl-[ACP] = (2E)-hexenoyl-[ACP] + H2O;
CC         Xref=Rhea:RHEA:41828, Rhea:RHEA-COMP:9630, Rhea:RHEA-COMP:9631,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78457, ChEBI:CHEBI:78458;
CC         Evidence={ECO:0000269|PubMed:18096506};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41829;
CC         Evidence={ECO:0000269|PubMed:18096506};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-hexenoyl-[ACP] + H(+) + NADPH = hexanoyl-[ACP] + NADP(+);
CC         Xref=Rhea:RHEA:41832, Rhea:RHEA-COMP:9631, Rhea:RHEA-COMP:9632,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78458, ChEBI:CHEBI:78459;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41833;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexanoyl-[ACP] + malonyl-[ACP] = 3-oxooctanoyl-[ACP] +
CC         CO2 + holo-[ACP]; Xref=Rhea:RHEA:41836, Rhea:RHEA-COMP:9623,
CC         Rhea:RHEA-COMP:9632, Rhea:RHEA-COMP:9633, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78449, ChEBI:CHEBI:78459, ChEBI:CHEBI:78460;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41837;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxooctanoyl-[ACP] + H(+) + NADPH = (3R)-hydroxyoctanoyl-
CC         [ACP] + NADP(+); Xref=Rhea:RHEA:41840, Rhea:RHEA-COMP:9633,
CC         Rhea:RHEA-COMP:9634, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78460, ChEBI:CHEBI:78461;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41841;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxyoctanoyl-[ACP] = (2E)-octenoyl-[ACP] + H2O;
CC         Xref=Rhea:RHEA:41844, Rhea:RHEA-COMP:9634, Rhea:RHEA-COMP:9635,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78461, ChEBI:CHEBI:78462;
CC         Evidence={ECO:0000269|PubMed:18096506};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41845;
CC         Evidence={ECO:0000269|PubMed:18096506};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-octenoyl-[ACP] + H(+) + NADPH = NADP(+) + octanoyl-[ACP];
CC         Xref=Rhea:RHEA:41848, Rhea:RHEA-COMP:9635, Rhea:RHEA-COMP:9636,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78462, ChEBI:CHEBI:78463;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41849;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + malonyl-[ACP] + octanoyl-[ACP] = 3-oxodecanoyl-[ACP] +
CC         CO2 + holo-[ACP]; Xref=Rhea:RHEA:41852, Rhea:RHEA-COMP:9623,
CC         Rhea:RHEA-COMP:9636, Rhea:RHEA-COMP:9637, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78449, ChEBI:CHEBI:78463, ChEBI:CHEBI:78464;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41853;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxodecanoyl-[ACP] + H(+) + NADPH = (3R)-hydroxydecanoyl-
CC         [ACP] + NADP(+); Xref=Rhea:RHEA:41856, Rhea:RHEA-COMP:9637,
CC         Rhea:RHEA-COMP:9638, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78464, ChEBI:CHEBI:78466;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41857;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxydecanoyl-[ACP] = (2E)-decenoyl-[ACP] + H2O;
CC         Xref=Rhea:RHEA:41860, Rhea:RHEA-COMP:9638, Rhea:RHEA-COMP:9639,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78466, ChEBI:CHEBI:78467;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41861;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-decenoyl-[ACP] + H(+) + NADPH = decanoyl-[ACP] + NADP(+);
CC         Xref=Rhea:RHEA:41864, Rhea:RHEA-COMP:9639, Rhea:RHEA-COMP:9640,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78467, ChEBI:CHEBI:78468;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41865;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=decanoyl-[ACP] + H(+) + malonyl-[ACP] = 3-oxododecanoyl-[ACP]
CC         + CO2 + holo-[ACP]; Xref=Rhea:RHEA:41868, Rhea:RHEA-COMP:9623,
CC         Rhea:RHEA-COMP:9640, Rhea:RHEA-COMP:9641, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78449, ChEBI:CHEBI:78468, ChEBI:CHEBI:78469;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41869;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxododecanoyl-[ACP] + H(+) + NADPH = (3R)-hydroxydodecanoyl-
CC         [ACP] + NADP(+); Xref=Rhea:RHEA:41872, Rhea:RHEA-COMP:9641,
CC         Rhea:RHEA-COMP:9642, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78469, ChEBI:CHEBI:78470;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41873;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxydodecanoyl-[ACP] = (2E)-dodecenoyl-[ACP] + H2O;
CC         Xref=Rhea:RHEA:41876, Rhea:RHEA-COMP:9642, Rhea:RHEA-COMP:9643,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78470, ChEBI:CHEBI:78472;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41877;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-dodecenoyl-[ACP] + H(+) + NADPH = dodecanoyl-[ACP] +
CC         NADP(+); Xref=Rhea:RHEA:41880, Rhea:RHEA-COMP:9643, Rhea:RHEA-
CC         COMP:9644, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:65264, ChEBI:CHEBI:78472;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41881;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-[ACP] + H(+) + malonyl-[ACP] = 3-oxotetradecanoyl-
CC         [ACP] + CO2 + holo-[ACP]; Xref=Rhea:RHEA:41884, Rhea:RHEA-COMP:9623,
CC         Rhea:RHEA-COMP:9644, Rhea:RHEA-COMP:9645, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:65264, ChEBI:CHEBI:78449, ChEBI:CHEBI:78473;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41885;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxotetradecanoyl-[ACP] + H(+) + NADPH = (3R)-
CC         hydroxytetradecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41888,
CC         Rhea:RHEA-COMP:9645, Rhea:RHEA-COMP:9646, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78473,
CC         ChEBI:CHEBI:78474; Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41889;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxytetradecanoyl-[ACP] = (2E)-tetradecenoyl-[ACP] +
CC         H2O; Xref=Rhea:RHEA:41892, Rhea:RHEA-COMP:9646, Rhea:RHEA-COMP:9647,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78474, ChEBI:CHEBI:78475;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41893;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-tetradecenoyl-[ACP] + H(+) + NADPH = NADP(+) +
CC         tetradecanoyl-[ACP]; Xref=Rhea:RHEA:41896, Rhea:RHEA-COMP:9647,
CC         Rhea:RHEA-COMP:9648, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78475, ChEBI:CHEBI:78477;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41897;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + malonyl-[ACP] + tetradecanoyl-[ACP] = 3-
CC         oxohexadecanoyl-[ACP] + CO2 + holo-[ACP]; Xref=Rhea:RHEA:41900,
CC         Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9648, Rhea:RHEA-COMP:9649,
CC         Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78477,
CC         ChEBI:CHEBI:78478; Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41901;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxohexadecanoyl-[ACP] + H(+) + NADPH = (3R)-
CC         hydroxyhexadecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41904, Rhea:RHEA-
CC         COMP:9649, Rhea:RHEA-COMP:9650, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78478, ChEBI:CHEBI:78480;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41905;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxyhexadecanoyl-[ACP] = (2E)-hexadecenoyl-[ACP] +
CC         H2O; Xref=Rhea:RHEA:41908, Rhea:RHEA-COMP:9650, Rhea:RHEA-COMP:9651,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78480, ChEBI:CHEBI:78481;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41909;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-hexadecenoyl-[ACP] + H(+) + NADPH = hexadecanoyl-[ACP] +
CC         NADP(+); Xref=Rhea:RHEA:41912, Rhea:RHEA-COMP:9651, Rhea:RHEA-
CC         COMP:9652, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:78481, ChEBI:CHEBI:78483;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41913;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexadecanoyl-[ACP] + malonyl-[ACP] = 3-oxooctadecanoyl-
CC         [ACP] + CO2 + holo-[ACP]; Xref=Rhea:RHEA:41916, Rhea:RHEA-COMP:9623,
CC         Rhea:RHEA-COMP:9652, Rhea:RHEA-COMP:9653, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479,
CC         ChEBI:CHEBI:78449, ChEBI:CHEBI:78483, ChEBI:CHEBI:78487;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41917;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-oxooctadecanoyl-[ACP] + H(+) + NADPH = (3R)-
CC         hydroxyoctadecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41920, Rhea:RHEA-
CC         COMP:9653, Rhea:RHEA-COMP:9654, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78487, ChEBI:CHEBI:78488;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41921;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(3R)-hydroxyoctadecanoyl-[ACP] = (2E)-octadecenoyl-[ACP] +
CC         H2O; Xref=Rhea:RHEA:41924, Rhea:RHEA-COMP:9654, Rhea:RHEA-COMP:9655,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:78488, ChEBI:CHEBI:78489;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41925;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-octadecenoyl-[ACP] + H(+) + NADPH = NADP(+) +
CC         octadecanoyl-[ACP]; Xref=Rhea:RHEA:41928, Rhea:RHEA-COMP:9655,
CC         Rhea:RHEA-COMP:9656, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:78489, ChEBI:CHEBI:78495;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41929;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + tetradecanoyl-[ACP] = H(+) + holo-[ACP] +
CC         tetradecanoate; Xref=Rhea:RHEA:30123, Rhea:RHEA-COMP:9648, Rhea:RHEA-
CC         COMP:9685, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30807,
CC         ChEBI:CHEBI:64479, ChEBI:CHEBI:78477; EC=3.1.2.14;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30124;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + octadecanoyl-[ACP] = H(+) + holo-[ACP] + octadecanoate;
CC         Xref=Rhea:RHEA:63204, Rhea:RHEA-COMP:9656, Rhea:RHEA-COMP:9685,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:25629,
CC         ChEBI:CHEBI:64479, ChEBI:CHEBI:78495;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63205;
CC         Evidence={ECO:0000250|UniProtKB:P49327};
CC   -!- ACTIVITY REGULATION: Cerulenin, a potent non-competitive
CC       pharmacological inhibitor of FAS, binds covalently to the active site
CC       of the condensing enzyme region, inactivating a key enzyme step in
CC       fatty acid synthesis (PubMed:16969344). Another inhibitor, though less
CC       efficient, is C75, a member of the alpha-methylene-gamma-butyrolactone
CC       chemical class, also proposed as an antitumour and anti-obesity agent
CC       (PubMed:15715522). {ECO:0000269|PubMed:15715522,
CC       ECO:0000269|PubMed:16969344}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=300 nmol/min/mg enzyme for the overall fatty acid synthase
CC         reaction {ECO:0000269|PubMed:15715522};
CC         Vmax=900 nmol/min/mg enzyme for the beta-ketoacyl reductase reaction
CC         of acetoacetyl-CoA {ECO:0000269|PubMed:15715522};
CC         Vmax=25 nmol/min/mg enzyme for the enoyl reductase reaction
CC         {ECO:0000269|PubMed:15715522};
CC         Vmax=25 nmol/min/mg enzyme for the thioesterase reaction
CC         {ECO:0000269|PubMed:15715522};
CC         Vmax=3 nmol/min/mg enzyme for the beta-ketoacyl synthase reaction
CC         {ECO:0000269|PubMed:15715522, ECO:0000269|PubMed:8250834};
CC         Vmax=16 nmol/min/ug enzyme for the transferase reaction using
CC         malonyl-CoA as donor {ECO:0000269|PubMed:8250834};
CC         Vmax=1.6 nmol/min/ug enzyme for the beta-ketoacyl reductase reaction
CC         of acetoacetyl-CoA {ECO:0000269|PubMed:8250834};
CC         Vmax=2.5 nmol/min/ug enzyme for the fatty acid synthase reaction
CC         {ECO:0000269|PubMed:8250834};
CC         Vmax=0.72 nmol/min/ug enzyme for the thioesterase reaction
CC         {ECO:0000269|PubMed:8250834};
CC         Vmax=1.9 nmol/min/ug enzyme for the enoyl reductase reaction
CC         {ECO:0000269|PubMed:8250834};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:15715522, ECO:0000269|PubMed:8250834,
CC       ECO:0000269|PubMed:8756713}.
CC   -!- SUBUNIT: Homodimer which is arranged in a head to tail fashion (By
CC       similarity). Interacts with CEACAM1; this interaction is insulin and
CC       phosphorylation-dependent; reduces fatty-acid synthase activity
CC       (PubMed:16054098). {ECO:0000250|UniProtKB:P49327,
CC       ECO:0000269|PubMed:16054098}.
CC   -!- INTERACTION:
CC       P12785; P12785: Fasn; NbExp=9; IntAct=EBI-493558, EBI-493558;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Melanosome
CC       {ECO:0000250}.
CC   -!- INDUCTION: Up-regulated in livers of rats fed on a high carbohydrate
CC       diet. {ECO:0000269|PubMed:2313386}.
CC   -!- PTM: S-nitrosylation of Fatty acid synthase at cysteine residues Cys-
CC       1464 or Cys-2085 is important for the enzyme dimerization. In
CC       adipocytes, S-nitrosylation of Fatty acid synthase occurs under
CC       physiological conditions and gradually increases during adipogenesis.
CC       {ECO:0000250|UniProtKB:P49327}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M76767; AAA57219.1; -; mRNA.
DR   EMBL; X62888; CAA44679.1; -; mRNA.
DR   EMBL; X62889; CAA44680.1; -; Genomic_DNA.
DR   EMBL; M84761; AAA41145.1; -; Genomic_DNA.
DR   EMBL; X13415; CAA31780.1; -; mRNA.
DR   EMBL; X13527; CAA31882.1; -; mRNA.
DR   EMBL; J03514; AAA41144.1; -; mRNA.
DR   PIR; A30313; XYRTFA.
DR   RefSeq; NP_059028.1; NM_017332.1.
DR   PDB; 2PNG; NMR; -; A=2114-2202.
DR   PDBsum; 2PNG; -.
DR   AlphaFoldDB; P12785; -.
DR   BMRB; P12785; -.
DR   SMR; P12785; -.
DR   BioGRID; 248415; 5.
DR   DIP; DIP-33893N; -.
DR   IntAct; P12785; 2.
DR   MINT; P12785; -.
DR   STRING; 10116.ENSRNOP00000064445; -.
DR   BindingDB; P12785; -.
DR   ChEMBL; CHEMBL3783; -.
DR   SwissLipids; SLP:000001864; -.
DR   ESTHER; ratno-fas; Thioesterase.
DR   CarbonylDB; P12785; -.
DR   GlyGen; P12785; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P12785; -.
DR   PhosphoSitePlus; P12785; -.
DR   jPOST; P12785; -.
DR   PaxDb; 10116-ENSRNOP00000064445; -.
DR   Ensembl; ENSRNOT00000073321.3; ENSRNOP00000064445.1; ENSRNOG00000045636.3.
DR   Ensembl; ENSRNOT00055056294; ENSRNOP00055046446; ENSRNOG00055032554.
DR   Ensembl; ENSRNOT00060015551; ENSRNOP00060012144; ENSRNOG00060009215.
DR   Ensembl; ENSRNOT00065007006; ENSRNOP00065004819; ENSRNOG00065004831.
DR   GeneID; 50671; -.
DR   KEGG; rno:50671; -.
DR   AGR; RGD:620665; -.
DR   CTD; 2194; -.
DR   RGD; 620665; Fasn.
DR   eggNOG; KOG1202; Eukaryota.
DR   GeneTree; ENSGT00940000157276; -.
DR   HOGENOM; CLU_000022_31_7_1; -.
DR   InParanoid; P12785; -.
DR   OrthoDB; 3378513at2759; -.
DR   PhylomeDB; P12785; -.
DR   Reactome; R-RNO-199220; Vitamin B5 (pantothenate) metabolism.
DR   Reactome; R-RNO-75105; Fatty acyl-CoA biosynthesis.
DR   SABIO-RK; P12785; -.
DR   UniPathway; UPA00094; -.
DR   EvolutionaryTrace; P12785; -.
DR   PRO; PR:P12785; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000045636; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0042587; C:glycogen granule; ISO:RGD.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0047450; F:(3R)-3-hydroxybutanoyl-[acyl-carrier-protein] hydratase activity; IEA:RHEA.
DR   GO; GO:0008693; F:(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activity; IEA:RHEA.
DR   GO; GO:0008659; F:(3R)-3-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity; IEA:RHEA.
DR   GO; GO:0047451; F:(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity; IEA:RHEA.
DR   GO; GO:0004317; F:(3R)-3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity; IEA:RHEA.
DR   GO; GO:0004316; F:3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004313; F:[acyl-carrier-protein] S-acetyltransferase activity; ISO:RGD.
DR   GO; GO:0004314; F:[acyl-carrier-protein] S-malonyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0141148; F:enoyl-[acyl-carrier-protein] reductase (NADPH) activity; IEA:UniProtKB-EC.
DR   GO; GO:0004312; F:fatty acid synthase activity; IDA:CACAO.
DR   GO; GO:0016297; F:fatty acyl-[ACP] hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR   GO; GO:0006084; P:acetyl-CoA metabolic process; IDA:RGD.
DR   GO; GO:0071353; P:cellular response to interleukin-4; ISO:RGD.
DR   GO; GO:0090557; P:establishment of endothelial intestinal barrier; ISO:RGD.
DR   GO; GO:0008611; P:ether lipid biosynthetic process; ISO:RGD.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IDA:RGD.
DR   GO; GO:0002068; P:glandular epithelial cell development; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0008610; P:lipid biosynthetic process; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0030224; P:monocyte differentiation; ISO:RGD.
DR   GO; GO:0030223; P:neutrophil differentiation; ISO:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0009888; P:tissue development; ISO:RGD.
DR   CDD; cd05195; enoyl_red; 1.
DR   CDD; cd08954; KR_1_FAS_SDR_x; 2.
DR   CDD; cd00833; PKS; 1.
DR   Gene3D; 3.30.70.3290; -; 1.
DR   Gene3D; 3.40.47.10; -; 1.
DR   Gene3D; 1.10.1200.10; ACP-like; 1.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 2.
DR   Gene3D; 3.40.366.10; Malonyl-Coenzyme A Acyl Carrier Protein, domain 2; 1.
DR   Gene3D; 3.90.180.10; Medium-chain alcohol dehydrogenases, catalytic domain; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   Gene3D; 3.10.129.110; Polyketide synthase dehydratase; 1.
DR   Gene3D; 3.40.50.150; Vaccinia Virus protein VP39; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR001227; Ac_transferase_dom_sf.
DR   InterPro; IPR036736; ACP-like_sf.
DR   InterPro; IPR014043; Acyl_transferase.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR049391; FAS_pseudo-KR.
DR   InterPro; IPR011032; GroES-like_sf.
DR   InterPro; IPR018201; Ketoacyl_synth_AS.
DR   InterPro; IPR014031; Ketoacyl_synth_C.
DR   InterPro; IPR014030; Ketoacyl_synth_N.
DR   InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR   InterPro; IPR013217; Methyltransf_12.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR032821; PKS_assoc.
DR   InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR   InterPro; IPR042104; PKS_dehydratase_sf.
DR   InterPro; IPR020807; PKS_DH.
DR   InterPro; IPR049552; PKS_DH_N.
DR   InterPro; IPR020843; PKS_ER.
DR   InterPro; IPR013968; PKS_KR.
DR   InterPro; IPR049900; PKS_mFAS_DH.
DR   InterPro; IPR050091; PKS_NRPS_Biosynth_Enz.
DR   InterPro; IPR020806; PKS_PP-bd.
DR   InterPro; IPR009081; PP-bd_ACP.
DR   InterPro; IPR006162; Ppantetheine_attach_site.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   InterPro; IPR001031; Thioesterase.
DR   InterPro; IPR016039; Thiolase-like.
DR   PANTHER; PTHR43775; FATTY ACID SYNTHASE; 1.
DR   PANTHER; PTHR43775:SF7; FATTY ACID SYNTHASE; 1.
DR   Pfam; PF00698; Acyl_transf_1; 1.
DR   Pfam; PF13602; ADH_zinc_N_2; 1.
DR   Pfam; PF21149; FAS_pseudo-KR; 1.
DR   Pfam; PF16197; KAsynt_C_assoc; 1.
DR   Pfam; PF00109; ketoacyl-synt; 1.
DR   Pfam; PF02801; Ketoacyl-synt_C; 1.
DR   Pfam; PF08659; KR; 1.
DR   Pfam; PF08242; Methyltransf_12; 1.
DR   Pfam; PF21089; PKS_DH_N; 1.
DR   Pfam; PF00550; PP-binding; 1.
DR   Pfam; PF00975; Thioesterase; 1.
DR   SMART; SM00827; PKS_AT; 1.
DR   SMART; SM00826; PKS_DH; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SMART; SM00822; PKS_KR; 1.
DR   SMART; SM00825; PKS_KS; 1.
DR   SMART; SM00823; PKS_PP; 1.
DR   SUPFAM; SSF47336; ACP-like; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   SUPFAM; SSF52151; FabD/lysophospholipase-like; 1.
DR   SUPFAM; SSF50129; GroES-like; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 2.
DR   SUPFAM; SSF55048; Probable ACP-binding domain of malonyl-CoA ACP transacylase; 1.
DR   SUPFAM; SSF53335; S-adenosyl-L-methionine-dependent methyltransferases; 1.
DR   SUPFAM; SSF53901; Thiolase-like; 1.
DR   PROSITE; PS50075; CARRIER; 1.
DR   PROSITE; PS00606; KS3_1; 1.
DR   PROSITE; PS52004; KS3_2; 1.
DR   PROSITE; PS00012; PHOSPHOPANTETHEINE; 1.
DR   PROSITE; PS52019; PKS_MFAS_DH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Hydrolase; Isopeptide bond; Lipid biosynthesis;
KW   Lipid metabolism; Lyase; Multifunctional enzyme; NAD; NADP; Oxidoreductase;
KW   Phosphopantetheine; Phosphoprotein; Pyridoxal phosphate;
KW   Reference proteome; S-nitrosylation; Transferase; Ubl conjugation.
FT   CHAIN           1..2505
FT                   /note="Fatty acid synthase"
FT                   /id="PRO_0000180279"
FT   DOMAIN          1..406
FT                   /note="Ketosynthase family 3 (KS3)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01348"
FT   DOMAIN          844..1112
FT                   /note="PKS/mFAS DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01363"
FT   DOMAIN          2113..2193
FT                   /note="Carrier"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   REGION          429..817
FT                   /note="Acyl and malonyl transferases"
FT   REGION          844..966
FT                   /note="N-terminal hotdog fold"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01363"
FT   REGION          983..1112
FT                   /note="C-terminal hotdog fold"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01363"
FT   REGION          1629..1857
FT                   /note="Enoyl reductase"
FT   REGION          1858..2113
FT                   /note="Beta-ketoacyl reductase"
FT   REGION          2202..2505
FT                   /note="Thioesterase"
FT   ACT_SITE        161
FT                   /note="For beta-ketoacyl synthase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01348"
FT   ACT_SITE        293
FT                   /note="For beta-ketoacyl synthase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01348"
FT   ACT_SITE        331
FT                   /note="For beta-ketoacyl synthase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01348"
FT   ACT_SITE        581
FT                   /note="For malonyltransferase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        878
FT                   /note="Proton acceptor; for dehydratase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01363"
FT   ACT_SITE        1032
FT                   /note="Proton donor; for dehydratase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01363"
FT   ACT_SITE        2302
FT                   /note="For thioesterase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   ACT_SITE        2475
FT                   /note="For thioesterase activity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT   BINDING         647..648
FT                   /ligand="an acyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:58342"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   BINDING         671
FT                   /ligand="an acyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:58342"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   BINDING         773
FT                   /ligand="an acyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:58342"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   BINDING         1665..1682
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /ligand_label="1"
FT                   /ligand_note="for enoyl reductase activity"
FT   BINDING         1765..1780
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /ligand_label="2"
FT                   /ligand_note="for ketoreductase activity"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         59
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         70
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         298
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         528
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         673
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         725
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         790
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   MOD_RES         993
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   MOD_RES         1276
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   MOD_RES         1464
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         1578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1588
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   MOD_RES         1698
FT                   /note="N6-(pyridoxal phosphate)lysine; alternate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1698
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         1765
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         1841
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         1989
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         2085
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         2151
FT                   /note="O-(pantetheine 4'-phosphoryl)serine; alternate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT   MOD_RES         2151
FT                   /note="Phosphoserine; alternate"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2191
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2230
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   MOD_RES         2385
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P19096"
FT   CROSSLNK        2443
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P49327"
FT   CONFLICT        184
FT                   /note="I -> T (in Ref. 3; AAA41145)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        871
FT                   /note="S -> P (in Ref. 4; CAA31780)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2085
FT                   /note="C -> P (in Ref. 6; AAA41144)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2106
FT                   /note="A -> V (in Ref. 1; AAA57219, 3; AAA41145 and 5;
FT                   CAA31882)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2296
FT                   /note="Y -> H (in Ref. 1; AAA57219 and 5; CAA31882)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2122..2124
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   HELIX           2126..2130
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   STRAND          2140..2142
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   HELIX           2144..2147
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   HELIX           2152..2164
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   HELIX           2171..2174
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   HELIX           2180..2184
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   STRAND          2188..2190
FT                   /evidence="ECO:0007829|PDB:2PNG"
FT   STRAND          2192..2194
FT                   /evidence="ECO:0007829|PDB:2PNG"
SQ   SEQUENCE   2505 AA;  272650 MW;  5810EC13D37F3114 CRC64;
     MEEVVIAGMS GKLPESENLQ EFWANLIGGV DMVTDDDRRW KAGLYGLPKR SGKLKDLSKF
     DASFFGVHPK QAHTMDPQLR LLLEVSYEAI VDGGINPASL RGTNTGVWVG VSGSEASEAL
     SRDPETLLGY SMVGCQRAMM ANRLSFFFDF KGPSIALDTA CSSSLLALQN AYQAIRSGEC
     PAAIVGGINL LLKPNTSVQF MKLGMLSPDG TCRSFDDSGN GYCRAEAVVA VLLTKKSLAR
     RVYATILNAG TNTDGCKEQG VTFPSGEAQE QLIRSLYQPG GVAPESLEYI EAHGTGTKVG
     DPQELNGITR SLCAFRQSPL LIGSTKSNMG HPEPASGLAA LTKVLLSLEN GVWAPNLHFH
     NPNPEIPALL DGRLQVVDRP LPVRGGIVGI NSFGFGGANV HVILQPNTQQ APAPAPHAAL
     PHLLHASGRT MEAVQGLLEQ GRQHSQDLAF VSMLNDIAAT PTAAMPFRGY TVLGVEGHVQ
     EVQQVPASQR PLWFICSGMG TQWRGMGLSL MRLDSFRESI LRSDEALKPL GVKVSDLLLS
     TDEHTFDDIV HSFVSLTAIQ IALIDLLTSM GLKPDGIIGH SLGEVACGYA DGCLSQREAV
     LAAYWRGQCI KDANLPAGSM AAVGLSWEEC KQRCPPGVVP ACHNSEDTVT ISGPQAAVNE
     FVEQLKQEGV FAKEVRTGGL AFHSYFMEGI APTLLQALKK VIREPRPRSA RWLSTSIPEA
     QWQSSLARTS SAEYNVNNLV SPVLFQEALW HVPEHAVVLE IAPHALLQAV LKRGVKPSCT
     IIPLMKRDHK DNLEFFLTNL GKVHLTGIDI NPNALFPPVE FPVPRGTPLI SPHIKWDHSQ
     TWDIPVAEDF PNGSSSSSAT VYNIDASSES SDHYLVDHCI DGRVLFPGTG YLYLVWKTLA
     RSLSLSLEET PVVFENVTFH QATILPRTGT VPLEVRLLEA SHAFEVSDSG NLIVSGKVYQ
     WEDPDSKLFD HPEVPIPAES ESVSRLTQGE VYKELRLRGY DYGPHFQGVY EATLEGEQGK
     LLWKDNWVTF MDTMLQISIL GFSKQSLQLP TRVTAIYIDP ATHLQKVYML EGDTQVADVT
     TSRCLGVTVS GGVYISRLQT TATSRRQQEQ LVPTLEKFVF TPHVEPECLS ESAILQKELQ
     LCKGLAKALQ TKATQQGLKM TVPGLEDLPQ HGLPRLLAAA CQLQLNGNLQ LELGEVLARE
     RLLLPEDPLI SGLLNSQALK ACIDTALENL STLKMKVVEV LAGEGHLYSH ISALLNTQPM
     LQLEYTATDR HPQALKDVQT KLQQHDVAQG QWDPSGPAPT NLGALDLVVC NCALATLGDP
     ALALDNMVAA LKDGGFLLMH TVLKGHALGE TLACLPSEVQ PGPSFLSQEE WESLFSRKAL
     HLVGLKKSFY GTALFLCRRL SPQDKPIFLP VEDTSFQWVD SLKSILATSS SQPVWLTAMN
     CPTSGVVGLV NCLRKEPGGH RIRCILLSNL SSTSHVPKLD PGSSELQKVL ESDLVMNVYR
     DGAWGAFRHF QLEQDKPEEQ TAHAFVNVLT RGDLASIRWV SSPLKHMQPP SSSGAQLCTV
     YYASLNFRDI MLATGKLSPD AIPGKWASRD CMLGMEFSGR DKCGRRVMGL VPAEGLATSV
     LLSPDFLWDV PSSWTLEEAA SVPVVYTTAY YSLVVRGRIQ HGETVLIHSG SGGVGQAAIS
     IALSLGCRVF TTVGSAEKRA YLQARFPQLD DTSFANSRDT SFEQHVLLHT GGKGVDLVLN
     SLAEEKLQAS VRCLAQHGRF LEIGKFDLSN NHPLGMAIFL KNVTFHGILL DALFEGANDS
     WREVAELLKA GIRDGVVKPL KCTVFPKAQV EDAFRYMAQG KHIGKVLVQV REEEPEAMLP
     GAQPTLISAI SKTFCPEHKS YIITGGLGGF GLELARWLVL RGAQRLVLTS RSGIRTGYQA
     KHVREWRRQG IHVLVSTSNV SSLEGARALI AEATKLGPVG GVFNLAMVLR DAMLENQTPE
     LFQDVNKPKY NGTLNLDRAT REACPELDYF VAFSSVSCGR GNAGQSNYGF ANSTMERICE
     QRRHDGLPGL AVQWGAIGDV GIILEAMGTN DTVVGGTLPQ RISSCMEVLD LFLNQPHAVL
     SSFVLAEKKA VAHGDGEAQR DLVKAVAHIL GIRDLAGINL DSSLADLGLD SLMGVEVRQI
     LEREHDLVLP IREVRQLTLR KLQEMSSKAG SDTELAAPKS KNDTSLKQAQ LNLSILLVNP
     EGPTLTRLNS VQSSERPLFL VHPIEGSITV FHSLAAKLSV PTYGLQCTQA APLDSIPNLA
     AYYIDCIKQV QPEGPYRVAG YSFGACVAFE MCSQLQAQQG PAPAHNNLFL FDGSHTYVLA
     YTQSYRAKLT PGCEAEAEAE AICFFIKQFV DAEHSKVLEA LLPLKSLEDR VAAAVDLITR
     SHQSLDRRDL SFAAVSFYYK LRAADQYKPK AKYHGNVILL RAKTGGTYGE DLGADYNLSQ
     VCDGKVSVHI IEGDHRTLLE GRGLESIINI IHSSLAEPRV SVREG
//
